PUBLIC COMPANY
save$OCGNOcugen, Inc.
$OCGN1.2800-2.29%Malvern, PA, USupdated 6d ago
community read0 votes
pipeline
7
marketed
0
phase 3
2
catalysts ytd
2
approvals ytd
0
recalls ytd
0
Pipeline(7)
pipeline depth7 products
2Preclinical1Phase 11Phase 22Phase 31Unknown
Phase 3
OCU-410ST
Juvenile Macular Degeneration (Stargardt Disease)
Phase 3baluretgene parvec
Retinitis Pigmentosa (Retinitis)
Phase 2OCU-410
Geographic Atrophy
Phase 1OCU-200
Diabetic Macular Edema
PreclinicalOCU-510
Seasonal Influenza
PreclinicalOCU-520
Coronavirus Disease 2019 (COVID-19)
drugadenovirus vector (spike protein) vaccine
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Insider activity
source: SEC Form 4routine RSU / option mechanics (6)
- Apr 1, 26option exerciseZhang Junge · 66,929 sh
- Apr 1, 26option exerciseZhang Junge · 112,205 sh
- Apr 1, 26option exerciseZhang Junge · 15,000 sh
- Apr 1, 26option exerciseZhang Junge · 15,000 sh
- Apr 1, 26option exerciseZhang Junge · 112,205 sh
- Apr 1, 26option exerciseZhang Junge · 66,929 sh
🐶 Hiring Signal
News
no news has mentioned this company yet
Data sources
last refreshed 3m ago
Found something off?
comments(0)
5-min edit window · permanent after that